Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
DA-1726
product2 mentionslast seen Nov 5, 2026
Novel oxyntomodulin analogue functioning as a glucagon-like peptide-1 receptor and glucagon receptor dual agonist for cardiometabolic indications.
Relationships 7
- MetaVia Inc.developsDA-172699% confidence2 sources
- DA-1726depends onoxyntomodulin analog94% confidence1 source
- DA-1726applies tocardiometabolic disease treatment94% confidence1 source
- DA-1726applies tometabolic dysfunction-associated liver disease93% confidence1 source
- DA-1726applies toalcohol-associated liver disease93% confidence1 source
- DA-1726depends onoxyntomodulin analogue92% confidence1 source
- DA-1726depends ondual GLP-1/glucagon receptor agonist90% confidence1 source
Relationship
DA-1726depends onoxyntomodulin analogue
92% confidence1 supporting mentions
Either name opens that entity’s relationships.
Sources 1